Frontiers in Cardiovascular Medicine

Original Research

Published on 23 Mar 2022

Alteration of N6-Methyladenosine mRNA Methylation in a Human Stem Cell-Derived Cardiomyocyte Model of Tyrosine Kinase Inhibitor-Induced Cardiotoxicity

in Cardio-Oncology

Yan Ma
Xian Liu
Yiming Bi
Tianhu Wang
Cheng Chen
Yabin Wang
Dong Han
Feng Cao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.849175

5,346 views
11 citations

Case Report

Published on 21 Mar 2022

Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy

in Cardio-Oncology

Shohei Moriyama
Mitsuhiro Fukata
Taku Yokoyama
Shohei Ueno
Takuya Nunomura
Yasuo Mori
Koji Kato
Toshihiro Miyamoto
Koichi Akashi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.848091

5,576 views
13 citations

Original Research

Published on 21 Mar 2022

Early Change in Area Strain Detected by 3D Speckle Tracking Is Associated With Subsequent Cardiotoxicity in Patients Treated With Low Doses of Anthracyclines

in Cardio-Oncology

Rafael B. Piveta
Ana Clara T. Rodrigues
Marcelo L. C. Vieira
Cláudio H. Fischer
Tania R. Afonso
Edgar Daminello
Felipe M. Cruz
Tatiana F. G. Galvão
Edgar B. L. Filho
Marcelo Katz

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.842532

3,156 views
12 citations

Systematic Review

Published on 17 Mar 2022

Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer

in Cardio-Oncology

Yinghui Wang
Yonggang Wang
Xiaorong Han
Jian Sun
Cheng Li
Binay Kumar Adhikari
Jin Zhang
Xiao Miao
Zhaoyang Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.727487

16,891 views
53 citations

Review

Published on 15 Mar 2022

Multimodality Advanced Cardiovascular and Molecular Imaging for Early Detection and Monitoring of Cancer Therapy-Associated Cardiotoxicity and the Role of Artificial Intelligence and Big Data

in Cardio-Oncology

Jennifer M. Kwan
Evangelos K. Oikonomou
Mariana L. Henry
Albert J. Sinusas

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.829553

8,803 views
28 citations

Original Research

Published on 11 Mar 2022

RNA Virus Gene Signatures Detected in Patients With Cardiomyopathy After Chemotherapy; A Pilot Study

in Cardio-Oncology

Kyle Varkoly
Shaoyuan Tan
Roxana Beladi
David Fonseca
Isabela Rivabem Zanetti
Simona Kraberger
Chintan Shah
Jordan R. Yaron
Liqiang Zhang
Michael Juby

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.821162

3,823 views
3 citations

Original Research

Published on 07 Mar 2022

MicroRNA-194-5p Attenuates Doxorubicin-Induced Cardiomyocyte Apoptosis and Endoplasmic Reticulum Stress by Targeting P21-Activated Kinase 2

in Cardio-Oncology

Hongge Fa
Dandan Xiao
Wenguang Chang
Lin Ding
Lanting Yang
Yu Wang
Mengyu Wang
Jianxun Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.815916

4,719 views
20 citations

Clinical Trial

Published on 07 Mar 2022

Relationship Between Serum Concentration of Adrenomedullin and Myocardial Ischemic T Wave Changes in Patients With Lung Cancer

in Cardio-Oncology

Chen Wu
Da-wei Lin
Yi-wen Jiang
Feng Jiang
Zhao-xia Wang
Yao-sheng Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.836993

2,584 views
2 citations

Case Report

Published on 01 Mar 2022

Case Series: Recovery of Chemotherapy-Related Acute Heart Failure by the Combined Use of Sacubitril Valsartan and Wearable Cardioverter Defibrillator: A Novel Winning Combination in Cardio-Oncology

in Cardio-Oncology

Maria Laura Canale
Katia Coviello
Gianluca Solarino
Jacopo Del Meglio
Federico Simonetti
Elio Venturini
Andrea Camerini
Nicola Maurea
Irma Bisceglia
Carlo Tessa

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.801143

4,901 views
6 citations

Review

Published on 25 Feb 2022

Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity

in Cardio-Oncology

De-Shu Chen
Jing Yan
Ping-Zhen Yang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.812578

6,922 views
20 citations

Original Research

Published on 21 Feb 2022

Regulation of Ion Channel Function in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Cancer Cell Secretion Through DNA Methylation

in Cardio-Oncology

Rujia Zhong
Feng Zhang
Zhen Yang
Yingrui Li
Qiang Xu
Huan Lan
Siegfried Lang
Lukas Cyganek
Elke Burgermeister
Ibrahim El-Battrawy

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.839104

4,008 views
4 citations

Original Research

Published on 17 Feb 2022

A Concomitant Cancer Diagnosis Is Associated With Poor Cardiovascular Outcomes Among Acute Myocardial Infarction Patients

in Cardio-Oncology

Xiang Peng
Zhuozhong Wang
Muhua Cao
Yuqi Zheng
Ya'nan Tian
Li Yu
Wenjun Ni
Shanjie Wang
Zhifeng Qin
Suhong Zhao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.758324

3,478 views
4 citations

Review

Published on 17 Feb 2022

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension

in Cardio-Oncology

Zhengqing Ba
Ying Xiao
Ming He
Dong Liu
Hao Wang
Hanyang Liang
Jiansong Yuan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.810262

12,043 views
15 citations

Brief Research Report

Published on 15 Feb 2022

BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors

in Cardio-Oncology

Biniyam G. Demissei
WenJian Lv
Nicholas S. Wilcox
Karyn Sheline
Amanda M. Smith
Kathleen M. Sturgeon
Chris McDermott-Roe
Kiran Musunuru
Bénédicte Lefebvre
Susan M. Domchek

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.833171

5,159 views
8 citations

Original Research

Published on 14 Feb 2022

Percutaneous Coronary Intervention in Patients With Gynecological Cancer: Machine Learning-Augmented Propensity Score Mortality and Cost Analysis for 383,760 Patients

in Cardio-Oncology

Nicole Thomason
Dominique J. Monlezun
Awad Javaid
Alexandru Filipescu
Efstratios Koutroumpakis
Fisayomi Shobayo
Peter Kim
Juan Lopez-Mattei
Mehmet Cilingiroglu
Gloria Iliescu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.793877

3,729 views
5 citations

Review

Published on 07 Feb 2022

New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging

in Cardio-Oncology

Farah Cadour
Franck Thuny
Joevin Sourdon

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.813883

4,347 views
14 citations

Case Report

Published on 31 Jan 2022

Capecitabine and Warfarin Interaction: A Case Report With Review of Literature and Management Options

in Cardio-Oncology

Khalefa Althiab
Manal Aljohani
Sultan Alraddadi
Mohammed Algarni

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.707361

5,828 views
2 citations

Policy and Practice Reviews

Published on 28 Jan 2022

Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

in Cardio-Oncology

Irma Bisceglia
Maria Laura Canale
Giuseppina Gallucci
Fabio Maria Turazza
Chiara Lestuzzi
Iris Parrini
Giulia Russo
Nicola Maurea
Vincenzo Quagliariello
Stefano Oliva

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.821193

12,618 views
5 citations

Original Research

Published on 28 Jan 2022

Soluble Urokinase Plasminogen Activator Receptor Is Associated With Subclinical Myocardial Impairment by Speckle Tracking Echocardiography in Lung Cancer Patients

in Cardio-Oncology

Ahmad S. Manshad
Fatima A. Ballout
Jeffrey A. Borgia
Jochen Reiser
Tochukwu M. Okwuosa

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.659524

2,611 views
4 citations

Mini Review

Published on 24 Jan 2022

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity

in Cardio-Oncology

Manrose Singh
Akito T. Nicol
Jaclyn DelPozzo
Jia Wei
Mandeep Singh
Tony Nguyen
Satoru Kobayashi
Qiangrong Liang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.839644

6,549 views
20 citations

Original Research

Published on 21 Jan 2022

D-Dimer Is a Predictive Factor of Cancer Therapeutics-Related Cardiac Dysfunction in Patients Treated With Cardiotoxic Chemotherapy

in Cardio-Oncology

Masayoshi Oikawa
Daiki Yaegashi
Tetsuro Yokokawa
Tomofumi Misaka
Takamasa Sato
Takashi Kaneshiro
Atsushi Kobayashi
Akiomi Yoshihisa
Kazuhiko Nakazato
Takafumi Ishida

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.807754

5,551 views
13 citations

Case Report

Published on 20 Jan 2022

Case Report: Two Myxomas of Different Echodensities on Transthoracic Echocardiography in One Patient

in Cardio-Oncology

Ling-Yun Kong
Xiao-Zheng Cui
Wei Xiang
Ling-Ling Chen
Li Li
Fang Liu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.770228

2,435 views
1 citation

Mini Review

Published on 17 Jan 2022

Novel Mechanisms of Anthracycline-Induced Cardiovascular Toxicity: A Focus on Thrombosis, Cardiac Atrophy, and Programmed Cell Death

in Cardio-Oncology

Silvio Antoniak
Sukanya Phungphong
Zhaokang Cheng
Brian C. Jensen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.817977

7,280 views
28 citations

Review

Published on 14 Jan 2022

Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity

in Cardio-Oncology

Dong-Woo Kang
Rebekah L. Wilson
Cami N. Christopher
Amber J. Normann
Oscar Barnes
Jordan D. Lesansee
Gyuhwan Choi
Christina M. Dieli-Conwright

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.805735

13,183 views
31 citations

386 articles

articles

Alteration of N6-Methyladenosine mRNA Methylation in a Human Stem Cell-Derived Cardiomyocyte Model of Tyrosine Kinase Inhibitor-Induced Cardiotoxicity

Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy

Early Change in Area Strain Detected by 3D Speckle Tracking Is Associated With Subsequent Cardiotoxicity in Patients Treated With Low Doses of Anthracyclines

Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer

Multimodality Advanced Cardiovascular and Molecular Imaging for Early Detection and Monitoring of Cancer Therapy-Associated Cardiotoxicity and the Role of Artificial Intelligence and Big Data

RNA Virus Gene Signatures Detected in Patients With Cardiomyopathy After Chemotherapy; A Pilot Study

MicroRNA-194-5p Attenuates Doxorubicin-Induced Cardiomyocyte Apoptosis and Endoplasmic Reticulum Stress by Targeting P21-Activated Kinase 2

Relationship Between Serum Concentration of Adrenomedullin and Myocardial Ischemic T Wave Changes in Patients With Lung Cancer

Case Series: Recovery of Chemotherapy-Related Acute Heart Failure by the Combined Use of Sacubitril Valsartan and Wearable Cardioverter Defibrillator: A Novel Winning Combination in Cardio-Oncology

Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity

Regulation of Ion Channel Function in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Cancer Cell Secretion Through DNA Methylation

A Concomitant Cancer Diagnosis Is Associated With Poor Cardiovascular Outcomes Among Acute Myocardial Infarction Patients

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension

BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors

Percutaneous Coronary Intervention in Patients With Gynecological Cancer: Machine Learning-Augmented Propensity Score Mortality and Cost Analysis for 383,760 Patients

New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging

Capecitabine and Warfarin Interaction: A Case Report With Review of Literature and Management Options

Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

Soluble Urokinase Plasminogen Activator Receptor Is Associated With Subclinical Myocardial Impairment by Speckle Tracking Echocardiography in Lung Cancer Patients

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity

D-Dimer Is a Predictive Factor of Cancer Therapeutics-Related Cardiac Dysfunction in Patients Treated With Cardiotoxic Chemotherapy

Case Report: Two Myxomas of Different Echodensities on Transthoracic Echocardiography in One Patient

Novel Mechanisms of Anthracycline-Induced Cardiovascular Toxicity: A Focus on Thrombosis, Cardiac Atrophy, and Programmed Cell Death

Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity